Analysis & Guidance Included. Always.
The convergence of fundamental research and regulatory requirements can be handled elegantly through thoughtful study design, excellent communication and perfect experimental execution.
Schedule a call to learn how IPST can deliver your pre-clinical research on-time and on-budget. Our 24 years of experience will strengthen your drug development pipeline.
Call today +1-819-820-1515 or email our Vice-President, Dan Salvail, Ph.D. at email@example.com
Let’s get the conversation started.
Dedicated to scientific excellence since 1999, IPS Therapeutique (IPST) specializes in the preclinical evaluation of the efficacy and safety of new drugs using validated and highly predictive models.
Reduce your costs of early drug development
De-risking pre-clinical drug candidates for scientists has been the focus of IPS Therapeutique (IPST) for 24 years; every in vivo model has been developed with this dual purpose in mind: confirm and define the conditions for efficacy, and identify early indicators of toxicity.
From proteomics to GLP-compliant safety pharmacology studies, IPST’s scientists understand the impact of attrition on drug discovery and use early detection of failure signals to lower the cost of pre-clinical development.